Journalist
Lee Hyo-jung
hyo@ajunews.com
-
Korea’s Biopharma CDMO Exports Hit Record Q1 High Despite Mideast Risks April 12, 2026
-
South Korea Medical AI Approvals Jump 2.5-Fold in Three Years, Reaching 157 in 2025 April 12, 2026
-
SK Bioscience Symposium, GC Pharma FDA Plasma Approval, Kolon Cancer Data, Korea Bio Response Hub April 9, 2026
-
Dongwha Pharm Names Shin Yong-jae Head of Jungseon Pharma’s Ho Chi Minh Office April 9, 2026
-
JW Pharmaceutical Signs Deal to Bring China’s Biweekly Obesity Drug Candidate to South Korea April 9, 2026
-
Samchundang Pharm Faces Growing Doubts Over Block Deal, S-Pass Tech and Patent Rights April 8, 2026
-
U.S. Leads Global Biotech for 15 Years as China Gains; South Korea Expands CDMO Footprint April 7, 2026
-
Celltrion’s Truxima Tops U.S. Rituximab Prescriptions, a First for a Korean Biosimilar April 7, 2026
-
Korea Medical Sector Warns of Supply Risks as Middle East War Drags On April 7, 2026
-
Korea Pharma-Bio Briefs: Celltrion, SK Bioscience, Hugel, Alteogen, CHA Hospital April 6, 2026
